VIS-FNG

N/A

Report date: 2025/04/15 16:50:51

Base Information

Drug NameVIS-FNG
Drug Alias Namebispecific monoclonal antibody (Visterra)VIS-FNG
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVisterra Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVir Biotechnology IncVisterra Inc
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A